How immune factors influence cancer development in Lynch Syndrome
Immune determinants modulating cancer development in Lynch Syndrome
This study is looking at how the immune system works in people with Lynch Syndrome, a genetic condition that raises the risk of cancer, to find better ways to prevent and treat cancer using new therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11114039 on NIH RePORTER |
What this research studies
This research investigates the immune mechanisms that affect cancer development in individuals with Lynch Syndrome, a hereditary condition that increases cancer risk. The study focuses on the role of specific mutations and immune responses in tumors associated with Lynch Syndrome, particularly how these factors may enhance the effectiveness of immune checkpoint inhibitors. By analyzing the immune profiles and tumor characteristics, the research aims to identify potential strategies for cancer prevention and treatment tailored to patients with this syndrome.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Lynch Syndrome who are at risk for developing certain types of cancer.
Not a fit: Patients without Lynch Syndrome or those who do not have a hereditary predisposition to cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer prevention strategies and more effective treatments for patients with Lynch Syndrome.
How similar studies have performed: Previous research has shown promising results in understanding immune responses in cancer, particularly in patients with high microsatellite instability, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Bhardwaj, Nina — Icahn School of Medicine at Mount Sinai
- Study coordinator: Bhardwaj, Nina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.